NYSE · LU
Lufax Holding financials
$1.24−1.59%
Close Sep 29, 2026 · split-adjustedRevenue
Net income
Income statement & cash flow
| Fiscal year | FY25 Dec 31 | FY24 Dec 31 | FY23 Dec 31 | FY22 Dec 31 | FY21 Dec 31 | FY20 Dec 31 |
|---|---|---|---|---|---|---|
| Revenue | $798.7M | $1.12B | $2.16B | $4.24B | $6.02B | $6.31B |
| Gross profit | $250.3M | $428.4M | $1.29B | $3.23B | $4.99B | $5.39B |
| Gross margin | 31.3% | 38.3% | 59.6% | 76.3% | 82.9% | 85.4% |
| Operating income | -$3.11B | -$2.48B | -$2.43B | -$2.14B | $229.2M | $1.46B |
| Net income | -$299.8M | -$530.3M | $114.4M | $1.13B | $2.64B | $2.74B |
| Net margin | −37.5% | −47.4% | 5.3% | 26.6% | 43.9% | 43.4% |
| Diluted EPS | $-0.17 | $-0.38 | $0.10 | $0.98 | $2.24 | $2.48 |
| EBITDA | -$733.8M | -$731.1M | -$610.6M | $253.0M | $1.31B | $1.97B |
| Operating cash flow | $2.04B | $569.2M | $2.19B | $718.3M | $2.04B | $1.74B |
| Free cash flow | $2.04B | $569.2M | $2.19B | $718.3M | $2.04B | $1.74B |
| Diluted shares | 1,733.4M | 1,395.1M | 1,146.2M | 1,145.1M | 1,181.9M | 1,104.2M |
Balance sheet
| Period end | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 |
|---|---|---|---|---|---|---|
| Cash & equivalents | $3.16B | $4.10B | $5.61B | $6.37B | $5.47B | $3.70B |
| Short-term investments | $5.18B | $3.08B | $3.75B | $5.13B | $5.48B | $6.27B |
| Total debt | $10.01B | $7.85B | $6.28B | $6.10B | $5.76B | $3.13B |
| Total assets | $29.75B | $27.89B | $33.11B | $50.88B | $56.71B | $38.10B |
| Total liabilities | $18.02B | $16.43B | $20.04B | $37.30B | $41.83B | $25.37B |
| Shareholders' equity | $11.73B | $11.45B | $13.07B | $13.58B | $14.88B | $12.73B |
From SEC filings via Massive. Fiscal periods follow the company's own calendar; free cash flow is operating cash flow minus capital expenditure.
Sources: Massive / Polygon daily aggregates (split-adjusted) · SEC filings via Massive · FINRA settlements via Massive · Financial Modeling Prep. Figures are dated where shown; research is informational, not investment advice. Methodology